Senolytic Vaccines from the Central and Peripheral Tolerance Perspective
Open Access
Abstract
Preventive medicine has proven its long-term effectiveness and economic feasibility. Over the last century, vaccination has saved more lives than any other medical technology. At present, preventative measures against most infectious diseases are successfully used worldwide; in addition, vaccination platforms against oncological and even autoimmune diseases are being actively developed. At the same time, the development of medicine led to an increase in both life expectancy and the proportion of age-associated diseases, which pose a heavy socio-economic burden. In this context, the development of vaccine-based approaches for the prevention or treatment of age-related diseases opens up broad prospects for extending the period of active longevity and has high economic potential. It is well known that the development of age-related diseases is associated with the accumulation of senescent cells in various organs and tissues. It has been demonstrated that the elimination of such cells leads to the restoration of functions, rejuvenation, and extension of the lives of experimental animals. However, the development of vaccines against senescent cells is complicated by their antigenic heterogeneity and the lack of a unique marker. In addition, senescent cells are the body’s own cells, which may be the reason for their low immunogenicity. This mini-review discusses the mechanisms of central and peripheral tolerance that may influence the formation of an anti-senescent immune response and be responsible for the accumulation of senescent cells with age.Keywords
Funding Information
- Russian Science Foundation (24-15-20003)
This publication has 207 references indexed in Scilit:
- Age-associated B cells in autoimmune diseasesCellular and Molecular Life Sciences, 2022
- Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down SyndromeJAMA Neurology, 2022
- Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gutActa Neuropathologica, 2021
- Apoptosis resistance of senescent cells is an intrinsic barrier for senolysis induced by cardiac glycosidesCellular and Molecular Life Sciences, 2021
- Dynamics of thymus function and T cell receptor repertoire breadth in health and diseaseSeminars in Immunopathology, 2021
- A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System AtrophyMovement Disorders, 2020
- Emerging use of senolytics and senomorphics against aging and chronic diseasesMedicinal Research Reviews, 2020
- Enterovirus infection is associated with an increased risk of childhood type 1 diabetes in Taiwan: a nationwide population-based cohort studyDiabetologia, 2014
- The Thymus and Central ToleranceClinical Immunology, 2000
- Bacterial Translocation from the Gastrointestinal Tract1999